montelukast

From Mont(r)e(al) +‎ -lukast (“leukotriene receptor antagonist”), named after the city of Montreal, where the drug was developed by Merck in 1991.

• (General American) IPA^(key): /ˌmɑn.təˈluːˌkæst/

• Audio (General American):

  (file)

montelukast (uncountable)

1. (pharmacology) A leukotriene antagonist (trademark Singulair) used orally in the form of its sodium salt C₃₅H₃₅ClNNaO₃S to treat asthma or to relieve the symptoms of seasonal allergic rhinitis.

• “montelukast”, in Merriam-Webster Online Dictionary, Springfield, Mass.: Merriam-Webster, 1996–present.

montelukast m (plural montelukast)

1. (pharmacology) montelukast